Header cover image

Japanese Pharmaceuticals & Biotech Your first investment

Results

9

0 new
Based on available information up to March 12, 2025, Donald Trump’s plans for oil and gas focus on maximizing U.S. production, reducing regulatory barriers, and prioritizing fossil fuels as a cornerstone of his energy policy. Here’s a concise overview of his intentions: Boost Production and Permitting: Trump has pledged to "unleash" American oil and gas by accelerating permitting processes. On his first day in office (January 20, 2025), he signed executive orders declaring a "national energy emergency" to fast-track approvals for energy infrastructure like pipelines, refineries, and power plants. This includes expanding drilling on federal lands and offshore areas, reversing Biden-era restrictions.

9 companies

Chugai Pharmaceutical

Market Cap: JP¥12.0t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

4519

JP¥7,219.00

7D

-0.3%

1Y

-0.3%

Otsuka Holdings

Market Cap: JP¥5.8t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

4578

JP¥10,865.00

7D

-1.5%

1Y

56.9%

Astellas Pharma

Market Cap: JP¥3.9t

Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

4503

JP¥2,155.50

7D

0.3%

1Y

44.7%

Shionogi

Market Cap: JP¥2.4t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

4507

JP¥2,831.50

7D

-0.4%

1Y

11.3%

Kyowa Kirin

Market Cap: JP¥1.4t

Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.

4151

JP¥2,590.00

7D

-2.1%

1Y

0.6%

Ono Pharmaceutical

Market Cap: JP¥1.1t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

4528

JP¥2,384.50

7D

1.6%

1Y

45.7%

Santen Pharmaceutical

Market Cap: JP¥639.2b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

4536

JP¥1,956.50

7D

-6.5%

1Y

16.4%

Tsumura

Market Cap: JP¥287.8b

Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.

4540

JP¥3,812.00

7D

-1.3%

1Y

4.0%

Nippon Shinyaku

Market Cap: JP¥270.9b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

4516

JP¥4,025.00

7D

0.9%

1Y

24.6%